A single enzyme that can generate all four nucleoside triphosphates, the building blocks of ribonucleic acid (RNA), has been ...

Explore LENN nanoparticles, a groundbreaking technology for delivering mRNA therapies to bladder cancer cells with enhanced ...

A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.

Researchers at Purdue University developed a virus-mimicking nanoparticle system that efficiently delivers mRNA to bladder ...

Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...

Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...

Moderna said it expects 2025 revenue of approximately $1.9 billion, which is $100 million above the midpoint previously ...

A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency ...

A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency ...